Superworth

ClearPoint Neuro EPS CLPT

Diluted earnings per share by quarter and over the last twelve months, from 2011.

Last 12 months, to Jun 30, 2026
−$1.18
Latest quarter, Q2 FY26
−$0.38
Fiscal year 2025
−$0.91

ClearPoint Neuro's earnings per share was −$1.18 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.38.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.91n/a
FY2024−$0.70n/a
FY2023−$0.91n/a
FY2022−$0.68n/a
FY2021−$0.67n/a
FY2020−$0.42n/a
FY2019−$0.43n/a
FY2018−$0.56n/a
FY2017−$1.12n/a
FY2016−$3.18n/a
FY2015−$4.39n/a
FY2014−$0.80n/a
FY2013−$4.80n/a
FY2012−$7.60n/a
FY2011−$20.80n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.38n/a−$1.18
Q1 FY26−$0.32n/a−$1.01
Q4 FY25−$0.27n/a−$0.91
Q3 FY25−$0.21n/a−$0.84
Q2 FY25−$0.21n/a−$0.81
Q1 FY25−$0.22n/a−$0.76
Q4 FY24−$0.20n/a−$0.70
Q3 FY24−$0.18n/a−$0.69
Q2 FY24−$0.16n/a−$0.71
Q1 FY24−$0.16n/a−$0.84
Q4 FY23−$0.19n/a−$0.91
Q3 FY23−$0.20n/a−$0.90

Against its peers

Companies in Medical - Instruments & Supplies nearest ClearPoint Neuro's size, closest first, today.

CompanyEPS, 12 monthsGrowth
CLPTClearPoint Neuro−$1.18
INFUInfuSystem$0.41+78% a year
UTMDUtah Medical Products$3.28−12% a year
EMBCEmbecta$1.47+3% a year
PDEXPro DEX$4.11+52% a year
TCMDTactile Systems Technology$1.08+74% a year
MDXGMimedx$0.04−81% a year
MOVMovado$1.80+137% a year
KEQUKewaunee Scientific$2.76−33% a year
IRMDIradimed$1.79+10% a year
STAAStaar Surgical$0.07
Peer median$1.63

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on ClearPoint Neuro

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.